Aion Therapeutic Inc.
ANTCFOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$2072064
P/E Ratio—
52W High$0.0197
52W Low$0.0013
Aion Therapeutic Inc. (ANTCF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ANTCF · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Oct 31, 2023EPS Actual
-$0.00
Revenue
—
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Oct 31, 2023
After Market Close
ANTCF reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.11
Rev. $0.17B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.11
Rev. Est.$0.17B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2023 | Oct 31, 2023 | — | -$0.00 | — | — | — | — |
| — Q3 FY2023 | Jul 31, 2023 | — | -$0.00 | — | — | — | — |
| — Q2 FY2023 | Apr 30, 2023 | — | -$0.00 | — | — | — | — |
| — Q1 FY2023 | Jan 31, 2023 | — | -$0.00 | — | — | — | — |
| — Q4 FY2022 | Oct 31, 2022 | — | -$0.00 | — | — | — | — |
| — Q3 FY2022 | Jul 31, 2022 | — | $0.00 | — | — | — | — |
| — Q2 FY2022 | Apr 30, 2022 | — | -$0.01 | — | — | — | — |
| — Q1 FY2022 | Jan 31, 2022 | — | -$0.00 | — | — | — | — |
Q4 FY2023
Oct 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Jul 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2023
Apr 30, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2023
Jan 31, 2023
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2022
Oct 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2022
Jul 31, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2022
Apr 30, 2022
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2022
Jan 31, 2022
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for ANTCF.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2023 | Oct 31, 2023 | — | $0.00 | — | — |
| — Q3 FY2023 | Jul 31, 2023 | — | $0.00 | $0.01 | +177.78% |
| — Q2 FY2023 | Apr 30, 2023 | — | $0.00 | $0.01 | +66.67% |
| — Q1 FY2023 | Jan 31, 2023 | — | $0.00 | $0.01 | +212.50% |
| — Q4 FY2022 | Oct 31, 2022 | — | $0.01 | $0.01 | -15.38% |
| — Q3 FY2022 | Jul 31, 2022 | — | $0.03 | $0.03 | +0.00% |
| — Q2 FY2022 | Apr 30, 2022 | — | $0.01 | $0.01 | -36.04% |
| — Q1 FY2022 | Jan 31, 2022 | — | No price data | $0.02 | — |
Q4 FY2023—
Report Date
Oct 31, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
—
Q3 FY2023+177.78%
Report Date
Jul 31, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q2 FY2023+66.67%
Report Date
Apr 30, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q1 FY2023+212.50%
Report Date
Jan 31, 2023
EPS Beat/Miss
—
Price Before
$0.00
Price After
$0.01
Q4 FY2022-15.38%
Report Date
Oct 31, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2022+0.00%
Report Date
Jul 31, 2022
EPS Beat/Miss
—
Price Before
$0.03
Price After
$0.03
Q2 FY2022-36.04%
Report Date
Apr 30, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2022—
Report Date
Jan 31, 2022
EPS Beat/Miss
—
Price Before
—
Price After
$0.02
Beat Rate0 / 8 quarters
Largest Move+212.50% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ANTCF ends December
Aion Therapeutic Inc. (ANTCF) most recently reported earnings on October 31, 2023 for Q4 FY2023, posting EPS of $-0.00 (in line with the analyst consensus of —). The next ANTCF earnings date is expected around September 1, 2026.
Each quarter, investors track ANTCF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ANTCF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ANTCF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ANTCF earnings · 4 questionsAion Therapeutic Inc.'s next earnings report is expected around September 1, 2026. ANTCF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ANTCF historically reports after market close (AMC).
ANTCF earnings datewhen is ANTCF earningsANTCF next earnings datewhen does ANTCF report earningsANTCF earnings calendar
▸ Source: FMP · Aion Therapeutic Inc. SEC filings · US GAAP · Aion Therapeutic Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026